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Poliomyelitis vaccine is exceedingly safe and very rar~ly
causes any unpleasant sequelae. This has been the
experience in the United States of America, the United
Kingdom and Sputh Africa.
The following case report illustrates an anaphylactic
reaction following 4 hours after the injection of polio-
myelitis vaccine. An unusual feature was the development
of tetany.
CASE REPORT
A 26-year-old European housewife has been suffering from
hay fever since the age of 14 years. For the past 18
months she had attacks which were considered to be asth-
matic. A skin test was carried out by a specialist in allergy
and the patient was found to be sensitive to mixed grass
pollen. Desensitization was carried out. During the course
of the desensitization, after the 5th injection, she required
to have poliomyelitis vaccine. The first injection of vaccine
(prepared by the Poliomyelitis Research Foundation, Johan-
nesburg) caused no difficulty. A month later the second
injection was given; within 4 hours she developed severe
abdominal cramps and vomiting. At first there was -no
respiratory embarrassment, but when the doctor was called,
the patient was collapsed and there was evidence of
peripheral circulatory failure and peripheral cyanosis. The
pulse was fast, blood pressure unrecordable, respiration was
rapid and wheezing, and she complained of severe abdomi-
nal pain. Manifestations of tetany were observed, the patient
exhibiting spontaneous carpopedal spasm and irritability of
the 'facial nerve (Chvostek's sign). Adrenaline was adminis-
tered immediately (0'5 m!. of a 1 in 1,000 solution, sub-
cutaneously) followed by 15 mg. of mephentermine sulphate
(wyamine) intravenously. There was an improvement for the
next half an hour, but then the patient's condition dete·rio-
rated. Promethazine (phenergan) was given intramuscularly
with ·good effect. Calcium gluconate solution i.ntravenously
appeared to improve the manifestations of tetany though irri-
tability of the facial nerve persisted for several hours after
the general condition had improved.
Treatment with antihistamine drugs and intravenous cal-
cium gluconate was continued for 24 hours. She was
:hen quite well and no other manifestations of sensitivity
developed. The patient had received several injections of
.penicillin 5 years and 7 years previously, with no ill effects.
COMMENT
Injections of poliomyelitis vaccine have been reported to
cause skin rashes as well as anaphylactic reactions. The
vaccine generally contains culture medium, horse serum
or bovine serum, soluble monkey protein from blood or
kidney, formaldehyde, preservatives, polio virus, and anti-
biotics (penicillin). The cultures are well washed to get rid
of the serum before the addition of the virus phase of
the medium and, according to regulations, the dilution of
serum should be less than I in 1,000,000.1
It is generally' assumed that the penicillin content, how-
ever minute, acts as the allergen in reactions to polio
vaccine. This assumption is based upon the observation
that a penicillin-free vaccine does not cause reactions in
sensitive patients and upon reports that penicillinase pro-
tects against reactions. Zimmerman2 described 6 patients,
all with a previous history of sensitivity to penicillin, -who
developed urticaria or bullous dermatitis a few days after
poliomyelitis vaccination. In all these patients the reaction
to the vaccine duplicated the previous reaction to penicillin
and there was rapid clearing of the condition after a
single injection of penicillinase. The patients did not react
when a penicillin-free vaccine was administered subse-
quently.
In the vaccine prepared by the Poliomyelitis Research
Foundation, Johannesburg, the amount of penicillin added
to the fluid used in preparing the cultures is lOO units per
ml., that is, per one dose, but in the final vaccine the
penicillin has deteriorated to such an extent that its
presence can no longer be detected. However, as Gear l
points out, though the bactericidal and static activities
may have diminished to vanishing point, its allergenic
capacity may not have altered to the same extent!
It has been reported from the USA3 that vaccines
prepared by commercial drug manufacturers in America
contained amounts of penicillin varying .from 0.001 /L./mL
to less than 20 /L./mL, but the amounts of penicillin re-
ported to have caused anaphylactic reactions is some-
times minute. Brierlein3 reported a patient developing
shock from an intracutaneous skin test with 3 one-
millionths of 1 unit of penicillin. This patient had a passive
transfer skin test positive to 1 in 25 dilution of polio-
myelitis vaccine.
Calculating from vaccine issues in the Union of South
Africa it is believed that approximately 750,000 persons
have been vaccinated and the total number of reactions
reported has been small. l However, most of the injections
have. been given to children, and children rarely manifest
anaphylaxis.4 Skin rashes, usually urticaria, have been
reported to the Poliomyelitis Research Foundation and
in a few children suffering from asthma the inoculation
has apparently precipitated attacks.
The patient described in the present paper was a highly
allergic subject who had received injections of penicillin
previously with no ill effect; indeed she did not react to
the first dose of vaccine. It is presumed that penicillin
is the offending constituent in this instance.
Of interest was the occurrence of tetany. Anaphylaxis
is usually accompanied by bradypnoea, but the increased
expiratory effort can conceivably cause respiratory alka-
losis with resulting increase in excitability of nerve tissue.
Anxiety would contribute to the process. In our patient,
it was debated whether hyperventilation alone accounted
for the clinical picture, but this did not explain the shock,
the bronchospasm, the fall in blood pressure, the abdomi-
nal manifestations, and the response to adrenaline.
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